Paramount Stock Falls 6% as Merger Legal Battle Intensifies, May 31

Paramount stock fell 6% to $11.04 on May 31 as the company braces for legal battles over its proposed $111 billion acquisition of Warner Bros. Discovery. Paramount hired top antitrust attorney Jeffrey Kessler to defend the deal against potential lawsuits from California and other state attorneys general. The merger, approved by shareholders in April, is set to close by July but faces uncertainty from regulatory challenges.

Stock Decline Reflects Deal Uncertainty

Paramount shares dropped 6% to $11.04 on May 31, down from $11.75 the previous day. The stock has fallen 14.4% over the past three months and trades 18.7% below its 52-week high of $13.59. Meyka rates the stock C+ with a Hold recommendation, reflecting weak fundamentals and limited upside potential.

California AG Signals Antitrust Challenge

California Attorney General Rob Bonta has expressed concern that the merger will lead to mass layoffs and consolidation of major news outlets. Paramount hired Jeffrey Kessler, co-executive chairman of Winston & Strawn, to lead the legal defense. Kessler previously led state attorneys’ successful case against Live Nation, making him a high-profile addition to Paramount’s legal team.

Deal Timeline and Regulatory Path

Warner Bros. shareholders approved the takeover in April. The deal is expected to close by July at the earliest, pending regulatory approval. The combined company would control CNN, CBS News, HBO, TBS, and four streaming services. State attorneys general have not yet filed lawsuits but have signaled their intent to scrutinize the consolidation.

Industry Response and Content Impact

AEW President Tony Khan praised CEO David Ellison and expressed optimism about the merger. Khan noted that keeping TBS and TNT under the same corporate roof as CBS was preferable to alternative outcomes. The deal would create a media giant with significant influence over sports, news, and entertainment content distribution.

Final Thoughts

Paramount’s 6% decline reflects investor concern over regulatory risk. With Meyka rating the stock C+ and analyst consensus at Hold, the deal’s legal uncertainty adds downside pressure until closure.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.